Merck is recognized for its expertise in cardiovascular disease, diabetes, lipid and thyroid disorders. By bringing together the individual indications in the Commercial Unit CardioMetabolic Care, Merck is pursuing a strategy that will benefit our customers, physicians and patients alike. The integration of our activities, from research to ultimately making the product available to the patient, will help to sharpen the focus on patients in various disease states.
Merck Serono Oncology is focused on developing novel cancer-specific therapies that provide beneficial therapeutic outcomes and create new options for cancer patients.
Key to Merck Serono’s success in oncology is the research and development of agents that not only have a combined approach when it comes to targeting tumor cells, the tumor microenvironment, and the innate and adaptive immune system, but also show potential for combination with standard cancer therapies and with other novel products in our pipeline.
Merck Serono is committed to bringing hope to people suffering from neurodegenerative diseases. We have a long-term commitment to the development of innovative treatments to help manage neurological disorders such as Multiple Sclerosis (MS) and Parkinson’s disease (PD).
Merck Serono is the world leader in fertility treatment. Our vision is to develop and market innovative, easy-to-use products to help infertile couples at every stage of the reproductive cycle: from follicular development to early pregnancy.

More about:
    •    Oncology
    •    Reproductive Health
    •    Inherited Metabolic Disorders